Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Trygve Holmøy

221 publications found

Original articles

Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS (2024)
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial
J Neurol (in press)
DOI 10.1007/s00415-024-12326-z, PubMed 38649522

Holmøy T (2024)
'Assisting their orphaned children when in need'
Tidsskr Nor Laegeforen, 144 (4)
DOI 10.4045/tidsskr.24.0066, PubMed 38506007

Novy C, Busk ØL, Tysnes OB, Landa SS, Aanjesen TN, Alstadhaug KB, Bjerknes TL, Bjørnå IK, Bråthen G, Dahl E, Demic N, Fahlström M, Flemmen HØ, Hallerstig E, HogenEsch I, Kampman MT, Kleveland G, Kvernmo HB, Ljøstad U, Maniaol A, Morsund AH, Nakken O, Olsen CG, Schlüter K, Utvik MS et al. (2024)
Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis
Brain Commun, 6 (2), fcae087
DOI 10.1093/braincomms/fcae087, PubMed 38585669

Nakken O, Aarseth JH, Wergeland S, Stigum H, Meyer HE, Holmøy T (2024)
BCG vaccination and multiple sclerosis risk: A Norwegian cohort study
Mult Scler, 13524585241230440 (in press)
DOI 10.1177/13524585241230440, PubMed 38414125

Kvistad CE, Lehmann AK, Kvistad SAS, Holmøy T, Lorentzen ÅR, Trovik LH, Kristoffersen EK, Bø L, Torkildsen Ø (2024)
Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway
Mult Scler, 13524585241231665 (in press)
DOI 10.1177/13524585241231665, PubMed 38345003

Havdal LB, Selvakumar J, Lund Berven L, Stiansen-Sonerud T, Zetterberg H, Blennow K, Holmøy T, Wyller VBB (2024)
Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19
Front Neurol, 15, 1345787
DOI 10.3389/fneur.2024.1345787, PubMed 38385031

Nygaard GO, Holmøy T (2024)
Norwegian health service should offer stem cell therapy for multiple sclerosis
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0770, PubMed 38349100

Olsen CG, Busk ØL, Holla ØL, Tveten K, Holmøy T, Tysnes OB, Høyer H (2024)
Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders
Amyotroph Lateral Scler Frontotemporal Degener, 25 (1-2), 177-187
DOI 10.1080/21678421.2023.2270705, PubMed 37849306

Ueland GÅ, Ueland HO, Stokland AM, Bhan A, Schønberg A, Sollid ST, Morgas DE, Holmøy T, Lima K, Methlie P, Løvås K, Torkildsen Ø, Husebye ES (2024)
Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease
J Clin Endocrinol Metab, 109 (2), 344-350
DOI 10.1210/clinem/dgad540, PubMed 37708353

Vaage AM, Benth JŠ, Meyer HE, Holmøy T, Nakken O (2023)
Premorbid lipid levels and long-term risk of ALS-a population-based cohort study
Amyotroph Lateral Scler Frontotemporal Degener, 25 (3-4), 358-366
DOI 10.1080/21678421.2023.2295455, PubMed 38117120

Nakken O, Vaage AM, Stigum H, Heldal E, Meyer HE, Holmøy T (2023)
Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
Brain Behav Immun Health, 34, 100704
DOI 10.1016/j.bbih.2023.100704, PubMed 38033614

Aspli KT, Aaseth JO, Holmøy T, Blennow K, Zetterberg H, Kirsebom BE, Fladby T, Selnes P (2023)
CSF, Blood, and MRI Biomarkers in Skogholt's Disease-A Rare Neurodegenerative Disease in a Norwegian Kindred
Brain Sci, 13 (11)
DOI 10.3390/brainsci13111511, PubMed 38002473

Rød BE, Wergeland S, Bjørnevik K, Holmøy T, Ulvestad E, Njølstad G, Myhr KM, Torkildsen Ø (2023)
Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy
Mult Scler Relat Disord, 79, 105037
DOI 10.1016/j.msard.2023.105037, PubMed 37804765

Ali AH, Benterud A, Holmøy T, Myro AZ (2023)
Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report
J Med Case Rep, 17 (1), 330
DOI 10.1186/s13256-023-04059-w, PubMed 37533037

Wolf AS, Ravussin A, König M, Øverås MH, Solum G, Kjønstad IF, Chopra A, Holmøy T, Harbo HF, Syversen SW, Jørgensen KK, Høgestøl EA, Vaage JT, Celius EG, Lund-Johansen F, Munthe LA, Nygaard GO, Mjaaland S (2023)
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
JCI Insight, 8 (12)
DOI 10.1172/jci.insight.165111, PubMed 37159281

Selvakumar J, Havdal LB, Drevvatne M, Brodwall EM, Lund Berven L, Stiansen-Sonerud T, Einvik G, Leegaard TM, Tjade T, Michelsen AE, Mollnes TE, Lund-Johansen F, Holmøy T, Zetterberg H, Blennow K, Sandler CX, Cvejic E, Lloyd AR, Wyller VBB (2023)
Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults
JAMA Netw Open, 6 (3), e235763
DOI 10.1001/jamanetworkopen.2023.5763, PubMed 36995712

Torkildsen Ø, Rød BE, Bø L, Wergeland S, Holmøy T, Myhr KM (2022)
Breastfeeding and treatment for multiple sclerosis
Tidsskr Nor Laegeforen, 142 (15)
DOI 10.4045/tidsskr.22.0529, PubMed 36286559

Nakken O, Holmøy T, Stigum H, Myhr KM, Dahl J, Heldal E, Meyer HE (2022)
Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study
Int J Epidemiol, 51 (5), 1637-1644
DOI 10.1093/ije/dyac039, PubMed 35278068

Ali AH, Høyer H, Rugland E, Holmøy T (2022)
[A.H. Ali et al. respond]
Tidsskr Nor Laegeforen, 142 (13)
DOI 10.4045/tidsskr.22.0560, PubMed 36164790

Ali AH, Høyer H, Rugland E, Holmøy T (2022)
A woman in her fifties with progressive walking difficulties
Tidsskr Nor Laegeforen, 142 (11)
DOI 10.4045/tidsskr.21.0522, PubMed 35997187

Eid K, Torkildsen Ø, Aarseth J, Celius EG, Cortese M, Holmøy T, Kapali A, Myhr KM, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH (2022)
Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
J Neurol, 269 (11), 5901-5909
DOI 10.1007/s00415-022-11249-x, PubMed 35780399

Lie IA, Wesnes K, Kvistad SS, Brouwer I, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Barkhof F, Vrenken H, Myhr KM, Bø L, Torkildsen Ø (2022)
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
Neurol Neuroimmunol Neuroinflamm, 9 (5)
DOI 10.1212/NXI.0000000000200008, PubMed 35738901

Lie IA, Kaçar S, Wesnes K, Brouwer I, Kvistad SS, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Varhaug KN, Vedeler CA, Barkhof F, Teunissen CE, Bø L, Torkildsen Ø, Myhr KM, Vrenken H (2022)
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
J Neurol Neurosurg Psychiatry, 93 (8), 849-57 (in press)
DOI 10.1136/jnnp-2021-328568, PubMed 35649699

Eid K, Torkildsen Ø, Aarseth J, Aalstad M, Bhan A, Celius EG, Cortese M, Daltveit AK, Holmøy T, Myhr KM, Riise T, Schüler S, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH (2022)
Association of adverse childhood experiences with the development of multiple sclerosis
J Neurol Neurosurg Psychiatry, 93 (6), 645-650
DOI 10.1136/jnnp-2021-328700, PubMed 35379699

Nordfalk JM, Holmøy T, Thomas O, Nylenna M, Gulbrandsen P (2022)
Training physicians in providing complex information to patients with multiple sclerosis: a randomised controlled trial
BMJ Open, 12 (3), e049817
DOI 10.1136/bmjopen-2021-049817, PubMed 35292486

König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO (2022)
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
JAMA Neurol, 79 (3), 307-309
DOI 10.1001/jamaneurol.2021.5109, PubMed 35072702

Lindeman I, Polak J, Qiao SW, Holmøy T, Høglund RA, Vartdal F, Berg-Hansen P, Sollid LM, Lossius A (2022)
Stereotyped B-cell responses are linked to IgG constant region polymorphisms in multiple sclerosis
Eur J Immunol, 52 (4), 550-565
DOI 10.1002/eji.202149576, PubMed 35094395

Kliest T, Van Eijk RPA, Al-Chalabi A, Albanese A, Andersen PM, Amador MDM, BrÅthen G, Brunaud-Danel V, Brylev L, Camu W, De Carvalho M, Cereda C, Cetin H, Chaverri D, Chiò A, Corcia P, Couratier P, De Marchi F, Desnuelle C, Van Es MA, Esteban J, Filosto M, GarcÍa Redondo A, Grosskreutz J, Hanemann CO et al. (2022)
Clinical trials in pediatric ALS: a TRICALS feasibility study
Amyotroph Lateral Scler Frontotemporal Degener, 23 (7-8), 481-488
DOI 10.1080/21678421.2021.2024856, PubMed 35172656

Olsen CG, Busk ØL, Aanjesen TN, Alstadhaug KB, Bjørnå IK, Braathen GJ, Breivik KL, Demic N, Flemmen HØ, Hallerstig E, HogenEsch I, Holla ØL, Jøntvedt AB, Kampman MT, Kleveland G, Kvernmo HB, Ljøstad U, Maniaol A, Morsund ÅH, Nakken O, Novy C, Rekand T, Schlüter K, Schüler S, Tveten K et al. (2022)
Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study
Neuroepidemiology, 56 (4), 271-282
DOI 10.1159/000525091, PubMed 35576897

Aspli KT, Holmøy T, Flaten TP, Whist JE, Aaseth JO (2021)
Skogholt's disease-A tauopathy precipitated by iron and copper?
J Trace Elem Med Biol, 70, 126915
DOI 10.1016/j.jtemb.2021.126915, PubMed 34959013

Høglund RAA, Meyer HE, Stigum H, Torkildsen Ø, Grytten N, Holmøy T, Nakken O (2021)
Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study
Neurology, 97 (23), e2253-e2261
DOI 10.1212/WNL.0000000000012957, PubMed 34697245

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
J Neurol Neurosurg Psychiatry, 94 (1), 19-22
DOI 10.1136/jnnp-2021-327612, PubMed 34670844

Tysnes OB, Holmøy T, Indrekvam S, Fondenæs O (2021)
Ventilation of patients with amyotrophic lateral sclerosis
Tidsskr Nor Laegeforen, 141 (8)
DOI 10.4045/tidsskr.20.1030, PubMed 34047159

Eid K, Torkildsen ØF, Aarseth J, Flemmen HØ, Holmøy T, Lorentzen ÅR, Myhr KM, Riise T, Simonsen C, Torkildsen CF, Wergeland S, Willumsen JS, Øksendal N, Gilhus NE, Bjørk MH (2021)
Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
Neurology, 96 (23), e2789-e2800
DOI 10.1212/WNL.0000000000012062, PubMed 33883236

Wesnes K, Myhr KM, Riise T, Kvistad SS, Torkildsen Ø, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Bjørnevik K (2021)
Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis
Mult Scler Relat Disord, 50, 102801
DOI 10.1016/j.msard.2021.102801, PubMed 33636616

Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Ross AP, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS (2020)
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis
Mult Scler Relat Disord, 46, 102492
DOI 10.1016/j.msard.2020.102492, PubMed 33039944

Holmoy T, Torkildsen O, Bo L (2020)
Treatment of multiple sclerosis under the COVID-19 pandemic
Tidsskr. Nor. Laegeforen., 140 (8), 763-766

Røsjø E, Lindstrøm JC, Holmøy T, Myhr KM, Varhaug KN, Torkildsen Ø (2020)
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
Front Neurol, 11, 329
DOI 10.3389/fneur.2020.00329, PubMed 32425877

Holmøy T, Torkildsen Ø, Bø L (2020)
Treatment of multiple sclerosis under the COVID-19 pandemic
Tidsskr Nor Laegeforen, 140 (8)
DOI 10.4045/tidsskr.20.0333, PubMed 32463200

Høglund RA, Bremel RD, Homan EJ, Torsetnes SB, Lossius A, Holmøy T (2020)
CD4⁺ T Cells in the Blood of MS Patients Respond to Predicted Epitopes From B cell Receptors Found in Spinal Fluid
Front Immunol, 11, 598
DOI 10.3389/fimmu.2020.00598, PubMed 32328067

Holmøy T, Bø L (2020)
[Continuous improvement in MS treatment]
Tidsskr Nor Laegeforen, 140 (5)
DOI 10.4045/tidsskr.20.0198, PubMed 32238971

Holmøy T, Fogdell-Hahn A, Svenningsson A (2019)
Serum sickness following rituximab therapy in multiple sclerosis
Neurol Clin Pract, 9 (6), 519-521
DOI 10.1212/CPJ.0000000000000685, PubMed 32042497

Storm-Larsen C, Myhr KM, Farbu E, Midgard R, Nyquist K, Broch L, Berg-Hansen P, Buness A, Holm K, Ueland T, Fallang LE, Burum-Auensen E, Hov JR, Holmøy T (2019)
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial
Mult Scler J Exp Transl Clin, 5 (4), 2055217319888767
DOI 10.1177/2055217319888767, PubMed 31798939

Hupperts R, Smolders J, Vieth R, Holmøy T, Marhardt K, Schluep M, Killestein J, Barkhof F, Beelke M, Grimaldi LME, SOLAR Study Group (2019)
Randomized trial of daily high-dose vitamin D₃ in patients with RRMS receiving subcutaneous interferon β-1a
Neurology, 93 (20), e1906-e1916
DOI 10.1212/WNL.0000000000008445, PubMed 31594857

Høglund RA, Torsetnes SB, Lossius A, Bogen B, Homan EJ, Bremel R, Holmøy T (2019)
Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner
Int J Mol Sci, 20 (19)
DOI 10.3390/ijms20194843, PubMed 31569504

Holmøy T, Fevang B, Olsen DB, Spigset O, Bø L (2019)
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
BMC Res Notes, 12 (1), 497
DOI 10.1186/s13104-019-4507-6, PubMed 31405369

Hoglund RA, Myro AZ, Zarnovicky S, Holmoy T (2019)
A young woman with seizures, visual disturbances and paralysis
Tidsskr. Nor. Laegeforen., 139 (11), 1069-1073

Nakken O, Meyer HE, Stigum H, Holmøy T (2019)
High BMI is associated with low ALS risk: A population-based study
Neurology, 93 (5), e424-e432
DOI 10.1212/WNL.0000000000007861, PubMed 31243073

Tomescu-Baciu A, Johansen JN, Holmøy T, Greiff V, Stensland M, de Souza GA, Vartdal F, Lossius A (2019)
Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis
J Neuroimmunol, 333, 576966
DOI 10.1016/j.jneuroim.2019.576966, PubMed 31153015

Myro AZ, Bjerke G, Zarnovicky S, Holmøy T (2018)
Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
BMC Pharmacol Toxicol, 19 (1), 75
DOI 10.1186/s40360-018-0267-5, PubMed 30454022

Holmøy T, Røsjø E, Zetterberg H, Blennow K, Lindstrøm JC, Steffensen LH, Kampman MT (2018)
Vitamin D supplementation and neurofilament light chain in multiple sclerosis
Acta Neurol Scand, 139 (2), 172-176
DOI 10.1111/ane.13037, PubMed 30317548

Tomescu-Baciu A, Vartdal F, Holmøy T, Vedeler CA, Lossius A (2018)
G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis
Ann Clin Transl Neurol, 5 (10), 1303-1309
DOI 10.1002/acn3.642, PubMed 30349866

Magelssen M, Holmøy T, Horn MA, Fondenæs OA, Dybwik K, Førde R (2018)
Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis
J Neurol, 265 (11), 2730-2736
DOI 10.1007/s00415-018-9054-x, PubMed 30218178

Høglund RA, Polak J, Vartdal F, Holmøy T, Lossius A (2018)
B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate
Mult Scler Relat Disord, 26, 90-95
DOI 10.1016/j.msard.2018.08.032, PubMed 30243235

Nakken O, Holmoy T, Sorum L (2018)
Genetic testing in amyotrophic lateral sclerosis
Tidsskr. Nor. Laegeforen., 138 (13), 1251-1255

Nakken O, Sørum L, Holmøy T (2018)
Genetic testing in amyotrophic lateral sclerosis
Tidsskr Nor Laegeforen, 138 (13)
DOI 10.4045/tidsskr.18.0193, PubMed 30180501

Kvistad SS, Myhr KM, Holmøy T, Benth JŠ, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Sagen JV, Torkildsen Ø (2018)
Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis
J Neuroimmunol, 323, 73-77
DOI 10.1016/j.jneuroim.2018.07.011, PubMed 30196837

Holmøy T, Torkildsen Ø, Zarnovicky S (2018)
Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
Case Rep Neurol Med, 2018, 5190794
DOI 10.1155/2018/5190794, PubMed 30112230

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø (2018)
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
Mult Scler, 25 (7), 987-993
DOI 10.1177/1352458518779925, PubMed 29862891

Nakken O, Lindstrøm JC, Holmøy T (2018)
Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway
J Neurol, 265 (6), 1295-1302
DOI 10.1007/s00415-018-8832-9, PubMed 29564602

Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T (2017)
Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers
Amyotroph Lateral Scler Frontotemporal Degener, 19 (3-4), 303-310
DOI 10.1080/21678421.2017.1418004, PubMed 29271248

Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I et al. (2017)
July 2017 ENCALS statement on edaravone
Amyotroph Lateral Scler Frontotemporal Degener, 18 (7-8), 471-474
DOI 10.1080/21678421.2017.1369125, PubMed 28975816

Høglund RA, Lossius A, Johansen JN, Homan J, Benth JŠ, Robins H, Bogen B, Bremel RD, Holmøy T (2017)
In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis
Front Immunol, 8, 1255
DOI 10.3389/fimmu.2017.01255, PubMed 29038659

Lossius A, Tomescu-Baciu A, Holmøy T, Vedeler CA, Røsjø E, Lorentzen ÅR, Casetta I, Vartdal F (2017)
Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis
Ann Clin Transl Neurol, 4 (10), 756-761
DOI 10.1002/acn3.451, PubMed 29046884

Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT (2017)
High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial
BMC Neurol, 17 (1), 67
DOI 10.1186/s12883-017-0851-0, PubMed 28376767

Holmøy T, von der Lippe H, Leegaard TM (2017)
Listeria monocytogenes infection associated with alemtuzumab - - a case for better preventive strategies
BMC Neurol, 17 (1), 65
DOI 10.1186/s12883-017-0848-8, PubMed 28376817

Nordin A, Akimoto C, Wuolikainen A, Alstermark H, Forsberg K, Baumann P, Pinto S, de Carvalho M, Hübers A, Nordin F, Ludolph AC, Weishaupt JH, Meyer T, Grehl T, Schweikert K, Weber M, Burkhardt C, Neuwirth C, Holmøy T, Morita M, Tysnes OB, Benatar M, Wuu J, Lange DJ, Bisgård C et al. (2016)
Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study
Amyotroph Lateral Scler Frontotemporal Degener, 18 (3-4), 256-264
DOI 10.1080/21678421.2016.1262423, PubMed 27936955

Simonsen CS, Celius EG, Brunborg C, Tallaksen C, Eriksen EF, Holmøy T, Moen SM (2016)
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
BMC Neurol, 16 (1), 252
DOI 10.1186/s12883-016-0771-4, PubMed 27919248

Holmøy T, Beiske AG, Zarnovicky S, Myro AZ, Røsjø E, Kerty E (2016)
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report
BMC Neurol, 16 (1), 197
DOI 10.1186/s12883-016-0720-2, PubMed 27756254

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM (2016)
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study
Mult Scler, 23 (7), 1018-1024
DOI 10.1177/1352458516671028, PubMed 27663872

Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T (2016)
Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study
J Neurol, 263 (12), 2378-2385
DOI 10.1007/s00415-016-8273-2, PubMed 27586392

Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø (2016)
No association of tobacco use and disease activity in multiple sclerosis
Neurol Neuroimmunol Neuroinflamm, 3 (4), e260
DOI 10.1212/NXI.0000000000000260, PubMed 27458599

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T (2016)
Effect of high-dose vitamin D₃ supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis
Mult Scler, 23 (3), 395-402
DOI 10.1177/1352458516654310, PubMed 27325604

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø (2016)
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients
Eur J Neurol, 23 (6), 1064-70
DOI 10.1111/ene.12986, PubMed 26998820

Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A (2016)
The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
Genes Immun, 17 (2), 118-27
DOI 10.1038/gene.2015.61, PubMed 26765264

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T (2015)
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
J Neurol, 262 (12), 2713-21
DOI 10.1007/s00415-015-7902-5, PubMed 26429571

Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø (2015)
Body mass index influence interferon-beta treatment response in multiple sclerosis
J Neuroimmunol, 288, 92-7
DOI 10.1016/j.jneuroim.2015.09.008, PubMed 26531700

Johansen JN, Vartdal F, Desmarais C, Tutturen AE, de Souza GA, Lossius A, Holmøy T (2015)
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome
Clin Immunol, 160 (2), 211-25
DOI 10.1016/j.clim.2015.06.001, PubMed 26055752

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M (2015)
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
Mult Scler, 22 (1), 104-11
DOI 10.1177/1352458515579444, PubMed 26014605

Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T (2015)
Impact of the environment on multiple sclerosis
Tidsskr Nor Laegeforen, 135 (9), 856-60
DOI 10.4045/tidsskr.14.0751, PubMed 25991624

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM (2015)
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
Mult Scler, 21 (14), 1856-64
DOI 10.1177/1352458515578770, PubMed 25948625

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T (2015)
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
J Neuroimmunol, 280, 21-8
DOI 10.1016/j.jneuroim.2015.02.001, PubMed 25773151

Beiske GA, Holmøy T, Beiske AG, Johannessen SI, Johannessen Landmark C (2015)
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis
Mult Scler Int, 2015, 317859
DOI 10.1155/2015/317859, PubMed 26221541

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C (2015)
The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis
Neuroepidemiology, 44 (3), 173-81
DOI 10.1159/000381779, PubMed 25967369

Lerum SV, Solbraekke KN, Holmøy T, Frich JC (2015)
Unstable terminality: negotiating the meaning of chronicity and terminality in motor neurone disease
Sociol Health Illn, 37 (1), 81-96
DOI 10.1111/1467-9566.12182, PubMed 25601066

Helland CB, Holmøy T, Gulbrandsen P (2015)
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study
Int J MS Care, 17 (3), 122-9
DOI 10.7224/1537-2073.2014-007, PubMed 26052257

Geis C, Ritter C, Ruschil C, Weishaupt A, Grünewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV (2014)
The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model
Exp Neurol, 265, 8-21
DOI 10.1016/j.expneurol.2014.12.015, PubMed 25542977

Aspli KT, Flaten TP, Roos PM, Holmøy T, Skogholt JH, Aaseth J (2014)
Iron and copper in progressive demyelination--New lessons from Skogholt's disease
J Trace Elem Med Biol, 31, 183-7
DOI 10.1016/j.jtemb.2014.12.002, PubMed 25563774

Vego H, Sand KL, Høglund RA, Fallang LE, Gundersen G, Holmøy T, Maghazachi AA (2014)
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
Cell Mol Immunol, 13 (1), 57-64
DOI 10.1038/cmi.2014.114, PubMed 25435072

Gulbrandsen P, Ofstad EH, Holmøy T, Vandvik PO (2014)
Shared decision-making in decisions on treatment
Tidsskr Nor Laegeforen, 134 (17), 1670-2
DOI 10.4045/tidsskr.14.0239, PubMed 25223676

Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J (2014)
High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
Eur J Immunol, 44 (11), 3439-52
DOI 10.1002/eji.201444662, PubMed 25103993

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM (2014)
Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study
Mult Scler, 21 (4), 388-95
DOI 10.1177/1352458514546785, PubMed 25182290

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O (2014)
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis
Mult Scler, 20 (14), 1833-40
DOI 10.1177/1352458514533843, PubMed 24842958

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T (2014)
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis
J Neuroimmunol, 271 (1-2), 60-5
DOI 10.1016/j.jneuroim.2014.03.014, PubMed 24713402

Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N (2014)
Month of birth and risk of multiple sclerosis: confounding and adjustments
Ann Clin Transl Neurol, 1 (2), 141-4
DOI 10.1002/acn3.37, PubMed 25356394

Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Pugliatti M (2014)
Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study
Mult Scler, 20 (8), 1042-9
DOI 10.1177/1352458513513968, PubMed 24414538

Lossius A, Riise T, Pugliatti M, Bjørnevik K, Casetta I, Drulovic J, Granieri E, Kampman MT, Landtblom AM, Lauer K, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Holmøy T (2013)
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study
Mult Scler, 20 (6), 669-74
DOI 10.1177/1352458513505693, PubMed 24072723

Holmøy T, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Saltytė Benth J, Torkildsen O, Wergeland S, Myhr KM, Michelsen AE, Aukrust P, Ueland T (2013)
Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity
PLoS One, 8 (9), e75021
DOI 10.1371/journal.pone.0075021, PubMed 24069377

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O (2013)
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway
J Neurol, 260 (6), 1481-8
DOI 10.1007/s00415-012-6814-x, PubMed 23292231

Høglund RA, Holmøy T, Harbo HF, Maghazachi AA (2013)
A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA)
PLoS One, 8 (4), e62237
DOI 10.1371/journal.pone.0062237, PubMed 23614042

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T (2013)
Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction
PLoS One, 8 (1), e54417
DOI 10.1371/journal.pone.0054417, PubMed 23349882

Torkildsen Ø, Løken-Amsrud KI, Wergeland S, Myhr KM, Holmøy T (2013)
Fat-soluble vitamins as disease modulators in multiple sclerosis
Acta Neurol Scand Suppl (196), 16-23
DOI 10.1111/ane.12045, PubMed 23190287

Siewers V, Holmoy T, Frich JC (2013)
Experiences with using mechanical in - exsufflation in amyotrophic lateral sclerosis
Eur. J. Physiother., 15 (4), 201-207
DOI 10.3109/21679169.2013.834513

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT (2012)
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway
Mult Scler, 19 (8), 1028-34
DOI 10.1177/1352458512471094, PubMed 23257620

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Holmøy T (2012)
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis
Mult Scler, 19 (4), 451-7
DOI 10.1177/1352458512457843, PubMed 22907941

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM (2012)
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment
Neurology, 79 (3), 267-73
DOI 10.1212/WNL.0b013e31825fdf01, PubMed 22700809

Østern R, Fagerheim T, Ørstavik K, Holmøy T, Heiberg A, Lund-Petersen I, Strom TM, Nilssen Ø, Dahl A (2012)
Hereditary motor neuron disease in a large Norwegian family with a "H46R" substitution in the superoxide dismutase 1 gene
Neuromuscul Disord, 22 (6), 511-21
DOI 10.1016/j.nmd.2012.01.011, PubMed 22475618

Holmøy T, Hanssen KT, Beiske AG (2012)
Patient satisfaction in rehabilitation of patients with multiple sclerosis
Tidsskr Nor Laegeforen, 132 (5), 523-6
DOI 10.4045/tidsskr.11.1043, PubMed 22398768

Moen SM, Celius EG, Sandvik L, Brustad M, Nordsletten L, Eriksen EF, Holmøy T (2012)
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study
PLoS One, 7 (9), e45703
DOI 10.1371/journal.pone.0045703, PubMed 23029191

Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Zhu B, Wolfson C (2012)
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q)
Acta Neurol Scand Suppl (195), 43-50
DOI 10.1111/ane.12032, PubMed 23278656

Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T (2012)
Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients
Neuroepidemiology, 39 (2), 84-93
DOI 10.1159/000339360, PubMed 22814117

Holmøy T, Torkildsen Ø, Myhr KM, Løken-Amsrud KI (2012)
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore
Acta Neurol Scand Suppl (195), 63-9
DOI 10.1111/ane.12028, PubMed 23278659

Lossius A, Vartdal F, Holmøy T (2011)
Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis
J Neuroimmunol, 240-241, 87-96
DOI 10.1016/j.jneuroim.2011.09.011, PubMed 22018702

Smolders J, Moen SM, Damoiseaux J, Huitinga I, Holmøy T (2011)
Vitamin D in the healthy and inflamed central nervous system: access and function
J Neurol Sci, 311 (1-2), 37-43
DOI 10.1016/j.jns.2011.07.033, PubMed 21862439

Holmøy T, Lossius A, Gundersen TE, Moen SM, Castellazzi M, Fainardi E, Casetta I (2011)
Intrathecal levels of vitamin D and IgG in multiple sclerosis
Acta Neurol Scand, 125 (6), e28-31
DOI 10.1111/j.1600-0404.2011.01577.x, PubMed 21781056

Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holmøy T (2011)
Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome
Neurology, 77 (2), 151-7
DOI 10.1212/WNL.0b013e3182242d34, PubMed 21747073

Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M, SOLAR study group (2011)
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial
J Neurol Sci, 311 (1-2), 44-9
DOI 10.1016/j.jns.2011.04.013, PubMed 21620416

Holmøy T, Braaten Ø, Hovden IA, Tallaksen CM (2011)
[A young woman with a weakening leg]
Tidsskr Nor Laegeforen, 131 (6), 583-6
DOI 10.4045/tidsskr.09.1499, PubMed 21423311

Pandya AD, Al-Jaderi Z, Høglund RA, Holmøy T, Harbo HF, Norgauer J, Maghazachi AA (2011)
Identification of human NK17/NK1 cells
PLoS One, 6 (10), e26780
DOI 10.1371/journal.pone.0026780, PubMed 22039549

Moen SM, Celius EG, Nordsletten L, Holmøy T (2011)
Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis
Acta Neurol Scand Suppl (191), 79-82
DOI 10.1111/j.1600-0404.2011.01548.x, PubMed 21711261

Kampman MT, Eriksen EF, Holmøy T (2011)
Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?
Acta Neurol Scand Suppl (191), 44-9
DOI 10.1111/j.1600-0404.2011.01543.x, PubMed 21711256

Høglund RA, Hestvik AL, Holmøy T, Maghazachi AA (2010)
Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate
Hum Immunol, 72 (2), 124-34
DOI 10.1016/j.humimm.2010.10.016, PubMed 20977917

Holmøy T, Geis C (2010)
The immunological basis for treatment of stiff person syndrome
J Neuroimmunol, 231 (1-2), 55-60
DOI 10.1016/j.jneuroim.2010.09.014, PubMed 20943276

Holmøy T, Wilson JA, von der Lippe C, Andersen PM, Berg-Hansen P (2010)
G127R: A novel SOD1 mutation associated with rapidly evolving ALS and severe pain syndrome
Amyotroph Lateral Scler, 11 (5), 478-80
DOI 10.3109/17482960903580315, PubMed 20192886

Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, Casetta I (2009)
25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis
Mult Scler, 15 (11), 1280-5
DOI 10.1177/1352458509107008, PubMed 19808741

Berg-Hansen P, Vandvik B, Fagerhol M, Holmøy T (2009)
Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis
J Neuroimmunol, 216 (1-2), 98-102
DOI 10.1016/j.jneuroim.2009.09.006, PubMed 19800696

Holmøy T, Skorstad G, Røste LS, Scheie D, Alvik K (2009)
Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord
Clin Neurol Neurosurg, 111 (8), 708-12
DOI 10.1016/j.clineuro.2009.06.005, PubMed 19616370

Skorstad G, Vandvik B, Vartdal F, Holmøy T (2009)
MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro
Eur J Neurol, 16 (10), 1124-9
DOI 10.1111/j.1468-1331.2009.02657.x, PubMed 19469834

Holmøy T, Aarrestad S, Engstrand P, Ottesen S, Syse A, Førde R (2009)
[Termination of mechanical ventilation in amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 129 (7), 628-31
DOI 10.4045/tidsskr.08.0006, PubMed 19337331

Hestvik AL, Skorstad G, Vartdal F, Holmøy T (2009)
Idiotope-specific CD4(+) T cells induce apoptosis of human oligodendrocytes
J Autoimmun, 32 (2), 125-32
DOI 10.1016/j.jaut.2009.01.004, PubMed 19250800

Holmøy T (2009)
The discovery of oligoclonal bands: a 50-year anniversary
Eur Neurol, 62 (5), 311-5
DOI 10.1159/000235944, PubMed 19729928

Holmøy T, Skorstad G, Hestvik AL, Alvik KM, Vartdal F (2009)
Protective and detrimental immunity: lessons from stiff person syndrome and multiple sclerosis
Acta Neurol Scand Suppl (189), 22-6
DOI 10.1111/j.1600-0404.2009.01207.x, PubMed 19566493

Skorstad G, Hestvik AL, Vartdal F, Holmøy T (2008)
Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome
J Autoimmun, 32 (1), 24-32
DOI 10.1016/j.jaut.2008.10.002, PubMed 19027267

Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, Holmøy T (2008)
GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence
Eur J Neurol, 15 (9), 973-80
DOI 10.1111/j.1468-1331.2008.02221.x, PubMed 18637036

Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T (2008)
Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid
Mult Scler, 14 (6), 749-58
DOI 10.1177/1352458508089411, PubMed 18611988

Holmøy T (2008)
The immunology of multiple sclerosis: disease mechanisms and therapeutic targets
Minerva Med, 99 (2), 119-40
PubMed 18431322

Holmøy T (2008)
T cells in amyotrophic lateral sclerosis
Eur J Neurol, 15 (4), 360-6
DOI 10.1111/j.1468-1331.2008.02065.x, PubMed 18266871

Holmoy T, Celius EG (2008)
Cost-effectiveness of natalizumab in multiple sclerosis
Expert Rev Pharmacoecon Outcomes Res, 8 (1), 11-21
DOI 10.1586/14737167.8.1.11, PubMed 20528351

Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, Riise T, Wolfson C (2008)
Environmental risk factors in multiple sclerosis
Acta Neurol Scand Suppl, 188, 34-40
DOI 10.1111/j.1600-0404.2008.01029.x, PubMed 18439219

Holmøy T (2008)
Medicine and the arts. Pesta on the Stairs by Theodor Kittelsen. Commentary
Acad Med, 83 (1), 74-5
DOI 10.1097/ACM.0b013e31815c65b8, PubMed 18162756

Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG (2007)
Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway
J Neurol, 255 (1), 49-55
DOI 10.1007/s00415-007-0659-8, PubMed 18080855

Hestvik AL, Vartdal F, Fredriksen AB, Thompson KM, Kvale EO, Skorstad G, Bogen B, Holmoy T (2007)
T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG
Scand J Immunol, 66 (4), 393-401
DOI 10.1111/j.1365-3083.2007.01955.x, PubMed 17850583

Holmøy T, Celius EG (2007)
[A rush job and knowledge handling]
Tidsskr Nor Laegeforen, 127 (15), 1961-2
PubMed 17700745

Holmøy T (2007)
Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis
Med Hypotheses, 70 (1), 66-9
DOI 10.1016/j.mehy.2007.04.030, PubMed 17574770

Frich JC, Holmøy T (2007)
Medicine and the arts. Rowing without Oars [excerpt] by Ulla-Carin Lindquist. Commentary
Acad Med, 82 (6), 594-5
DOI 10.1097/ACM.0b013e31805567d6, PubMed 17525548

Holmøy T, Horn MA, Vandvik B (2007)
[A stiff-legged man with a bizarre gait]
Tidsskr Nor Laegeforen, 127 (11), 1529-30
PubMed 17566229

Holmøy T (2007)
Immunopathogenesis of multiple sclerosis: concepts and controversies
Acta Neurol Scand Suppl, 187, 39-45
DOI 10.1111/j.1600-0404.2007.00845.x, PubMed 17419827

Holmøy T, Frich JC (2006)
[Stories about life with amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 126 (24), 3297-9
PubMed 17170792

Leirvik A, Liverød M, Holmøy T (2006)
[Quality of life of patients with amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 126 (19), 2520-2
PubMed 17028632

Holmøy T, Worren T (2006)
[Communication aids in amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 126 (19), 2523-5
PubMed 17028633

Holmøy T, Roos PM, Kvale EØ (2006)
ALS: cytokine profile in cerebrospinal fluid T-cell clones
Amyotroph Lateral Scler, 7 (3), 183-6
DOI 10.1080/17482960600664730, PubMed 16963408

Holmøy T, Philip AA (2006)
Medicine and the arts. Three Elling Solheim poems translated by Alison Arderne Philip. Commentary
Acad Med, 81 (5), 474-5
DOI 10.1097/01.ACM.0000222269.67835.fa, PubMed 16639206

Holmøy T (2006)
A Norse contribution to the history of neurological diseases
Eur Neurol, 55 (1), 57-8
DOI 10.1159/000091431, PubMed 16479124

Holmøy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F (2005)
Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells
Eur J Immunol, 35 (6), 1786-94
DOI 10.1002/eji.200425417, PubMed 15864781

Holmøy T, Kvale EØ, Vartdal F (2004)
Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein
J Neurovirol, 10 (5), 278-83
DOI 10.1080/13550280490499524, PubMed 15385250

Holmøy T, Vartdal F (2004)
Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells
J Neurovirol, 10 (1), 52-6
DOI 10.1080/13550280490261671, PubMed 14982728

Holmøy T, Vandvik B, Vartdal F (2003)
T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid
Mult Scler, 9 (3), 228-34
DOI 10.1191/1352458503ms906oa, PubMed 12814167

Holmøy T, Berg-Johnsen J, Magnaes B (1999)
[Early postoperative complications in carotid surgery]
Tidsskr Nor Laegeforen, 119 (7), 922-4
PubMed 10210950

Holmøy T, Sandberg L (1996)
[Painless femoral neck fracture in a patient with multiple sclerosis]
Tidsskr Nor Laegeforen, 116 (2), 249
PubMed 8633335

Holmøy T (1993)
[Cerebellar infarctions]
Tidsskr Nor Laegeforen, 113 (20), 2564-5
PubMed 8236175

Review articles

Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø (2020)
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
J Neurol, 268 (12), 4522-4536
DOI 10.1007/s00415-020-10235-5, PubMed 33011853

Gilmour BC, Gudmundsrud R, Frank J, Hov A, Lautrup S, Aman Y, Røsjø H, Brenner C, Ziegler M, Tysnes OB, Tzoulis C, Omland T, Søraas A, Holmøy T, Bergersen LH, Storm-Mathisen J, Nilsen H, Fang EF (2020)
Targeting NAD⁺ in translational research to relieve diseases and conditions of metabolic stress and ageing
Mech Ageing Dev, 186, 111208
DOI 10.1016/j.mad.2020.111208, PubMed 31953124

Smolders J, Torkildsen Ø, Camu W, Holmøy T (2019)
An Update on Vitamin D and Disease Activity in Multiple Sclerosis
CNS Drugs, 33 (12), 1187-1199
DOI 10.1007/s40263-019-00674-8, PubMed 31686407

Myhr KM, Torkildsen Ø, Lossius A, Bø L, Holmøy T (2019)
B cell depletion in the treatment of multiple sclerosis
Expert Opin Biol Ther, 19 (3), 261-271
DOI 10.1080/14712598.2019.1568407, PubMed 30632834

Holmøy T, Torkildsen Ø, Myhr KM (2017)
An update on cladribine for relapsing-remitting multiple sclerosis
Expert Opin Pharmacother, 18 (15), 1627-1635
DOI 10.1080/14656566.2017.1372747, PubMed 28858531

Lossius A, Johansen JN, Vartdal F, Holmøy T (2016)
High-throughput sequencing of immune repertoires in multiple sclerosis
Ann Clin Transl Neurol, 3 (4), 295-306
DOI 10.1002/acn3.295, PubMed 27081660

Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T (2012)
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation
Viruses, 4 (12), 3701-30
DOI 10.3390/v4123701, PubMed 23342374

Holmøy T, Kampman MT, Smolders J (2012)
Vitamin D in multiple sclerosis: implications for assessment and treatment
Expert Rev Neurother, 12 (9), 1101-12
DOI 10.1586/ern.12.99, PubMed 23039389

Holmøy T, Celius EG (2011)
[Development of new therapies for multiple sclerosis]
Tidsskr Nor Laegeforen, 131 (8), 832-6
DOI 10.4045/tidsskr.10.0077, PubMed 21556088

Holmøy T, Moen SM (2010)
Assessing vitamin D in the central nervous system
Acta Neurol Scand Suppl (190), 88-92
DOI 10.1111/j.1600-0404.2010.01383.x, PubMed 20586743

Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B (2009)
The idiotype connection: linking infection and multiple sclerosis
Trends Immunol, 31 (2), 56-62
DOI 10.1016/j.it.2009.11.001, PubMed 19962346

Holmøy T, Harbo H, Vartdal F, Spurkland A (2009)
Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update
Curr Mol Med, 9 (5), 591-611
DOI 10.2174/156652409788488793, PubMed 19601809

Holmøy T, Hestvik AL (2008)
Multiple sclerosis: immunopathogenesis and controversies in defining the cause
Curr Opin Infect Dis, 21 (3), 271-8
DOI 10.1097/QCO.0b013e3282f88b48, PubMed 18448972

Holmøy T, Vartdal F (2007)
The immunological basis for treatment of multiple sclerosis
Scand J Immunol, 66 (4), 374-82
DOI 10.1111/j.1365-3083.2007.01982.x, PubMed 17850581